Cytokinetics
CYTK
#2403
Rank
A$11.09 B
Marketcap
A$90.74
Share price
-3.67%
Change (1 day)
12.72%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2025 (TTM): -A$1.17 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are A$87.21 Million. In 2024 the company made an earning of -A$0.85 Billion a decrease over its 2023 earnings that were of -A$0.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$1.17 Billion37.87%
2024 -A$0.85 Billion12.03%
2023 -A$0.76 Billion35.3%
2022 -A$0.56 Billion80.65%
2021 -A$0.31 Billion69.15%
2020 -A$0.19 Billion4.6%
2019 -A$0.18 Billion14.49%
2018 -A$0.16 Billion-16.83%
2017 -A$0.19 Billion-812.8%
2016 A$25.74 M-147.81%
2015 -A$53.86 Million156.05%
2014 -A$21.04 Million-56.56%
2013 -A$48.42 Million-16.48%
2012 -A$57.98 Million-15.65%
2011 -A$68.73 Million-3.24%
2010 -A$71.03 Million-308.68%
2009 A$34.03 M-141.87%
2008 -A$81.29 Million0.21%
2007 -A$81.12 Million-7.91%
2006 -A$88.09 Million37.42%
2005 -A$64.1 Million16.13%
2004 -A$55.2 Million-19.29%
2003 -A$68.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$11.83 B-1,196.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-A$44.6 Million-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$95.91 M-108.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.4 Billion-63.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$6.33 M-100.59%๐Ÿ‡บ๐Ÿ‡ธ USA